According to a small retrospective study, AF patients may help reduce the amount of time spent in the hospital when they are given Dabigatran. The reason for this is because newer anticoagulants like Dabigatran take out some of the steps involved in getting the medication to target anticoagulation levels in the same manner as Warfarin. In fact, researchers say that it can get AF patients out of hospitals as much as hours or even a day sooner.
Researchers analyzed information collected from 36 patients who were recently diagnosed with AF and hospitalized. What they learned was that of the patients given anticoagulation medication, 18 of them who were given Dabigatran were able to leave the hospital about a day earlier than those given other medications. The study’s senior author was Dr. David A Vorchheimer (Mount Sinai Heart Institute, New York, NY).
These results may prove significant since Warfarin can take days to reach therapeutic anticoagulation levels. According to Vorchheimer, “in our small snapshot [of patients in clinical practice], it seems to make sense that if you have a drug with a shorter onset of action and a shorter time to therapeutic anticoagulation, you can get the patient out of the hospital faster.”
AF is a condition that is characterized by patients experiencing irregular heartbeats or flutters. It is treated with various different methods including anticoagulant medications like Multaq. Multaq is made by Sanofi-Aventis and has been linked to serious side effects including a worsening of the heart condition, liver failure and lung toxicity.
If you or a loved one has suffered from liver failure or a worsening heart condition after being treated with Multaq, contact the attorneys at Greg Jones today for a free consultation. I am experienced at fighting Multaq lawsuits and may be able to help you recover money for your injuries.